United States Biotechnology & Medical Research

MapLight Therapeutics Inc (MPLT)

Track

Over the last 90 days, MapLight Therapeutics Inc. has seen significant insider selling, with a net value of -$1,042,053.57. The CEO, Christopher A. Kroeger, and General Counsel, Kristopher Hanson, were notably active in planned sales. This activity occurred despite a strong 90-day stock price increase of 66.3%.

Top insider sells (90d)

Top cluster sells (90d)

Top executive sells (90d)

Featured in screeners

Top insider sells

Top cluster sells

Top executive sells

Stock chart

Ticker: MPLT Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Kroeger Christopher A.

Chief Executive Officer

2 sales — total 3,215,000 USD

Planned sale 18 May 2026

Value US$4,237,402.59 | Price 474.12 | Shares 97,146

Planned sale 18 May 2026

Value US$562,593.80 | Price 420.29 | Shares 53,168

Kroeger Christopher A.

Chief Executive Officer

4 sales — total 421,002 USD

Planned sale 11 May 2026

Value US$2,382,060.19 | Price 364.87 | Shares 24,652

Planned sale 11 May 2026

Value US$4,239,610.36 | Price 430.41 | Shares 68,030

Planned sale 11 May 2026

Value US$25,169.90 | Price 28.70 | Shares 877

Planned sale 11 May 2026

Value US$9,428.94 | Price 27.57 | Shares 342

Hanson Kristopher

General Counsel

4 sales — total 419,263 USD

Planned sale 11 May 2026

Value US$177,492.48 | Price 30.56 | Shares 5,808

Planned sale 11 May 2026

Value US$209,649.16 | Price 30.04 | Shares 6,979

Planned sale 11 May 2026

Value US$24,280.20 | Price 28.70 | Shares 846

Planned sale 11 May 2026

Value US$7,841.24 | Price 27.61 | Shares 284

Kroeger Christopher A.

Chief Executive Officer

3 sales — total 952,835 USD

Planned sale 8 May 2026

Value US$93,586.00 | Price 29.20 | Shares 3,205

Planned sale 8 May 2026

Value US$45,181.92 | Price 28.56 | Shares 1,582

Planned sale 8 May 2026

Value US$814,067.52 | Price 27.48 | Shares 29,624

Foff Erin Pennock

Chief Medical Officer

2 sales — total 126,640 USD

Planned sale 7 May 2026

Value US$3,404.70 | Price 29.10 | Shares 117

Planned sale 7 May 2026

Value US$123,234.92 | Price 28.52 | Shares 4,321

Kroeger Christopher A.

Chief Executive Officer

2 sales — total 575,797 USD

Planned sale 7 May 2026

Value US$152,163.00 | Price 29.15 | Shares 5,220

Planned sale 7 May 2026

Value US$423,633.60 | Price 28.47 | Shares 14,880

Lillie James Woodruff

Chief Scientific Officer

1 sale — total 20,390 USD

Planned sale 7 May 2026

Value US$20,389.88 | Price 28.28 | Shares 721

Kroeger Christopher A.

Chief Executive Officer

2 sales — total 681,583 USD

Planned sale 6 May 2026

Value US$454,515.39 | Price 29.13 | Shares 15,603

Planned sale 6 May 2026

Value US$227,067.92 | Price 28.04 | Shares 8,098

Setia Vishwas

Chief Financial Officer

2 sales — total 298,345 USD

Planned sale 6 May 2026

Value US$60,116.76 | Price 29.07 | Shares 2,068

Planned sale 6 May 2026

Value US$238,227.84 | Price 28.04 | Shares 8,496

Lillie James Woodruff

Chief Scientific Officer

2 sales — total 713,599 USD

Planned sale 6 May 2026

Value US$478,343.73 | Price 29.13 | Shares 16,421

Planned sale 6 May 2026

Value US$235,255.60 | Price 28.04 | Shares 8,390

Foff Erin Pennock

Chief Medical Officer

2 sales — total 691,749 USD

Planned sale 6 May 2026

Value US$463,167.00 | Price 29.13 | Shares 15,900

Planned sale 6 May 2026

Value US$228,582.08 | Price 28.04 | Shares 8,152

Kroeger Christopher A.

Chief Executive Officer

2 sales — total 295,289 USD

Planned sale 5 May 2026

Value US$26,912.00 | Price 29.00 | Shares 928

Planned sale 5 May 2026

Value US$268,377.28 | Price 28.12 | Shares 9,544

Setia Vishwas

Chief Financial Officer

2 sales — total 307,444 USD

Planned sale 5 May 2026

Value US$28,072.00 | Price 29.00 | Shares 968

Planned sale 5 May 2026

Value US$279,372.20 | Price 28.12 | Shares 9,935

Lillie James Woodruff

Chief Scientific Officer

2 sales — total 312,839 USD

Planned sale 5 May 2026

Value US$27,927.00 | Price 29.00 | Shares 963

Planned sale 5 May 2026

Value US$284,911.84 | Price 28.12 | Shares 10,132

Foff Erin Pennock

Chief Medical Officer

2 sales — total 298,216 USD

Planned sale 5 May 2026

Value US$26,999.00 | Price 29.00 | Shares 931

Planned sale 5 May 2026

Value US$271,217.40 | Price 28.12 | Shares 9,645

Kroeger Christopher A.

Chief Executive Officer

5 sales — total 7,694,992 USD

Planned sale 4 May 2026

Value US$20,965.76 | Price 30.08 | Shares 697

Planned sale 4 May 2026

Value US$9,193.16 | Price 29.56 | Shares 311

Planned sale 4 May 2026

Value US$153,963.99 | Price 28.37 | Shares 5,427

Planned sale 4 May 2026

Value US$251,240.00 | Price 27.50 | Shares 9,136

Proposed sale 4 May 2026

Value US$7,259,629.00 | Price 30.70 | Shares 236,470

Setia Vishwas

Chief Financial Officer

5 sales — total 1,535,520 USD

Planned sale 4 May 2026

Value US$23,704.44 | Price 30.12 | Shares 787

Planned sale 4 May 2026

Value US$9,607.00 | Price 29.56 | Shares 325

Planned sale 4 May 2026

Value US$254,208.92 | Price 28.28 | Shares 8,989

Planned sale 4 May 2026

Value US$131,410.08 | Price 27.36 | Shares 4,803

Proposed sale 4 May 2026

Value US$1,116,589.70 | Price 30.70 | Shares 36,371

Hanson Kristopher

General Counsel

5 sales — total 1,242,681 USD

Planned sale 4 May 2026

Value US$20,544.64 | Price 30.08 | Shares 683

Planned sale 4 May 2026

Value US$8,749.76 | Price 29.56 | Shares 296

Planned sale 4 May 2026

Value US$110,557.32 | Price 28.29 | Shares 3,908

Planned sale 4 May 2026

Value US$248,325.00 | Price 27.50 | Shares 9,030

Proposed sale 4 May 2026

Value US$854,503.80 | Price 30.70 | Shares 27,834

Lillie James Woodruff

Chief Scientific Officer

5 sales — total 2,051,353 USD

Planned sale 4 May 2026

Value US$21,206.40 | Price 30.08 | Shares 705

Planned sale 4 May 2026

Value US$9,459.20 | Price 29.56 | Shares 320

Planned sale 4 May 2026

Value US$156,772.62 | Price 28.37 | Shares 5,526

Planned sale 4 May 2026

Value US$254,375.00 | Price 27.50 | Shares 9,250

Proposed sale 4 May 2026

Value US$1,609,539.60 | Price 30.70 | Shares 52,428

Foff Erin Pennock

Chief Medical Officer

5 sales — total 2,117,472 USD

Planned sale 4 May 2026

Value US$21,056.00 | Price 30.08 | Shares 700

Planned sale 4 May 2026

Value US$9,222.72 | Price 29.56 | Shares 312

Planned sale 4 May 2026

Value US$154,900.20 | Price 28.37 | Shares 5,460

Planned sale 4 May 2026

Value US$252,450.00 | Price 27.50 | Shares 9,180

Proposed sale 4 May 2026

Value US$1,679,842.60 | Price 30.70 | Shares 54,718

GILLIS JONATHAN

CAAO and PAO

3 sales — total 1,067,056 USD

Planned sale 28 Apr 2026

Value US$21,581.00 | Price 30.83 | Shares 700

Planned sale 28 Apr 2026

Value US$522,737.55 | Price 30.33 | Shares 17,235

Planned sale 28 Apr 2026

Value US$522,737.55 | Price 30.33 | Shares 17,235

Kreitzer Anatol

Chief Discovery Officer

3 sales — total 1,347,066 USD

Planned sale 27 Apr 2026

Value US$238,540.50 | Price 30.50 | Shares 7,821

Planned sale 27 Apr 2026

Value US$866,825.65 | Price 29.63 | Shares 29,255

Planned sale 27 Apr 2026

Value US$241,700.16 | Price 28.96 | Shares 8,346

GILLIS JONATHAN

CAAO and PAO

4 sales — total 1,980,866 USD

Planned sale 27 Apr 2026

Value US$437,496.98 | Price 30.46 | Shares 14,363

Planned sale 27 Apr 2026

Value US$437,496.98 | Price 30.46 | Shares 14,363

Planned sale 27 Apr 2026

Value US$876,840.80 | Price 29.60 | Shares 29,623

Planned sale 27 Apr 2026

Value US$229,031.16 | Price 28.94 | Shares 7,914

JONATHAN GILLIS

Officer

1 sale — total 2,078,290 USD

Proposed sale 27 Apr 2026

Value US$2,078,289.60 | Price 29.76 | Shares 69,835

ANATOL KREITZER

Officer

1 sale — total 1,351,759 USD

Proposed sale 27 Apr 2026

Value US$1,351,758.72 | Price 29.76 | Shares 45,422

Setia Vishwas

Chief Financial Officer

2 sales — total 3,175 USD

Sale 16 Apr 2026

Value US$2,391.63 | Price 27.49 | Shares 87

Sale 16 Apr 2026

Value US$783.29 | Price 27.01 | Shares 29

Kroeger Christopher A.

Chief Executive Officer

2 sales — total 275,141 USD

Sale 16 Apr 2026

Value US$208,236.75 | Price 27.49 | Shares 7,575

Sale 16 Apr 2026

Value US$66,903.77 | Price 27.01 | Shares 2,477

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-05-18	2026-05-18	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	97,146 -16.1% 474.12 US$4,237,403	97,146 -16.1%	474.12	US$4,237,403
2026-05-18	2026-05-18	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	53,168 -0.8% 420.29 US$562,594	53,168 -0.8%	420.29	US$562,594
2026-05-11	2026-05-11	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	24,652 +8.8% 364.87 US$2,382,060	24,652 +8.8%	364.87	US$2,382,060
2026-05-11	2026-05-11	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	6,871 -0.5% 30.04 US$206,405	6,871 -0.5%	30.04	US$206,405
2026-05-11	2026-05-11	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	877 -0.1% 28.70 US$25,170	877 -0.1%	28.70	US$25,170
2026-05-11	2026-05-11	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	342 -0.0% 27.57 US$9,429	342 -0.0%	27.57	US$9,429
2026-05-11	2026-05-11	PlS Planned sale	Hanson Kristopher General Counsel Officer	5,808 -3.5% 30.56 US$177,492	5,808 -3.5%	30.56	US$177,492
2026-05-11	2026-05-11	PlS Planned sale	Hanson Kristopher General Counsel Officer	6,979 -4.0% 30.04 US$209,649	6,979 -4.0%	30.04	US$209,649
2026-05-11	2026-05-11	PlS Planned sale	Hanson Kristopher General Counsel Officer	846 -0.5% 28.70 US$24,280	846 -0.5%	28.70	US$24,280
2026-05-11	2026-05-11	PlS Planned sale	Hanson Kristopher General Counsel Officer	284 -0.2% 27.61 US$7,841	284 -0.2%	27.61	US$7,841
2026-05-11	2026-05-08	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	3,205 -0.2% 29.20 US$93,586	3,205 -0.2%	29.20	US$93,586
2026-05-11	2026-05-08	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	1,582 -0.1% 28.56 US$45,182	1,582 -0.1%	28.56	US$45,182
2026-05-11	2026-05-08	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	29,624 -1.9% 27.48 US$814,068	29,624 -1.9%	27.48	US$814,068
2026-05-11	2026-05-07	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	117 -0.0% 29.10 US$3,405	117 -0.0%	29.10	US$3,405
2026-05-11	2026-05-07	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	4,321 -1.2% 28.52 US$123,235	4,321 -1.2%	28.52	US$123,235
2026-05-11	2026-05-07	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	5,220 -0.3% 29.15 US$152,163	5,220 -0.3%	29.15	US$152,163
2026-05-11	2026-05-07	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	14,880 -0.9% 28.47 US$423,634	14,880 -0.9%	28.47	US$423,634
2026-05-11	2026-05-07	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	721 -0.3% 28.28 US$20,390	721 -0.3%	28.28	US$20,390
2026-05-06	2026-05-06	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	15,603 -1.0% 29.13 US$454,515	15,603 -1.0%	29.13	US$454,515
2026-05-06	2026-05-06	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	8,098 -0.5% 28.04 US$227,068	8,098 -0.5%	28.04	US$227,068
2026-05-06	2026-05-06	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	2,068 -0.6% 29.07 US$60,117	2,068 -0.6%	29.07	US$60,117
2026-05-06	2026-05-06	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	8,496 -2.3% 28.04 US$238,228	8,496 -2.3%	28.04	US$238,228
2026-05-06	2026-05-06	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	16,421 -6.3% 29.13 US$478,344	16,421 -6.3%	29.13	US$478,344
2026-05-06	2026-05-06	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	8,390 -3.1% 28.04 US$235,256	8,390 -3.1%	28.04	US$235,256
2026-05-06	2026-05-06	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	15,900 -4.3% 29.13 US$463,167	15,900 -4.3%	29.13	US$463,167
2026-05-06	2026-05-06	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	8,152 -2.2% 28.04 US$228,582	8,152 -2.2%	28.04	US$228,582
2026-05-06	2026-05-05	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	928 -0.1% 29.00 US$26,912	928 -0.1%	29.00	US$26,912
2026-05-06	2026-05-05	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	9,544 -0.6% 28.12 US$268,377	9,544 -0.6%	28.12	US$268,377
2026-05-06	2026-05-05	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	968 -0.3% 29.00 US$28,072	968 -0.3%	29.00	US$28,072
2026-05-06	2026-05-05	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	9,935 -2.6% 28.12 US$279,372	9,935 -2.6%	28.12	US$279,372
2026-05-06	2026-05-05	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	963 -0.4% 29.00 US$27,927	963 -0.4%	29.00	US$27,927
2026-05-06	2026-05-05	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	10,132 -3.6% 28.12 US$284,912	10,132 -3.6%	28.12	US$284,912
2026-05-06	2026-05-05	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	931 -0.2% 29.00 US$26,999	931 -0.2%	29.00	US$26,999
2026-05-06	2026-05-05	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	9,645 -2.5% 28.12 US$271,217	9,645 -2.5%	28.12	US$271,217
2026-05-06	2026-05-04	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	697 -0.0% 30.08 US$20,966	697 -0.0%	30.08	US$20,966
2026-05-06	2026-05-04	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	311 -0.0% 29.56 US$9,193	311 -0.0%	29.56	US$9,193
2026-05-06	2026-05-04	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	5,427 -0.3% 28.37 US$153,964	5,427 -0.3%	28.37	US$153,964
2026-05-06	2026-05-04	PlS Planned sale	Kroeger Christopher A. Chief Executive Officer Executive Director	9,136 -0.6% 27.50 US$251,240	9,136 -0.6%	27.50	US$251,240
2026-05-06	2026-05-04	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	787 -0.2% 30.12 US$23,704	787 -0.2%	30.12	US$23,704
2026-05-06	2026-05-04	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	325 -0.1% 29.56 US$9,607	325 -0.1%	29.56	US$9,607
2026-05-06	2026-05-04	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	8,989 -2.3% 28.28 US$254,209	8,989 -2.3%	28.28	US$254,209
2026-05-06	2026-05-04	PlS Planned sale	Setia Vishwas Chief Financial Officer Officer	4,803 -1.2% 27.36 US$131,410	4,803 -1.2%	27.36	US$131,410
2026-05-06	2026-05-04	PlS Planned sale	Hanson Kristopher General Counsel Officer	683 -0.4% 30.08 US$20,545	683 -0.4%	30.08	US$20,545
2026-05-06	2026-05-04	PlS Planned sale	Hanson Kristopher General Counsel Officer	296 -0.2% 29.56 US$8,750	296 -0.2%	29.56	US$8,750
2026-05-06	2026-05-04	PlS Planned sale	Hanson Kristopher General Counsel Officer	3,908 -2.2% 28.29 US$110,557	3,908 -2.2%	28.29	US$110,557
2026-05-06	2026-05-04	PlS Planned sale	Hanson Kristopher General Counsel Officer	9,030 -4.7% 27.50 US$248,325	9,030 -4.7%	27.50	US$248,325
2026-05-06	2026-05-04	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	705 -0.3% 30.08 US$21,206	705 -0.3%	30.08	US$21,206
2026-05-06	2026-05-04	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	320 -0.1% 29.56 US$9,459	320 -0.1%	29.56	US$9,459
2026-05-06	2026-05-04	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	5,526 -1.9% 28.37 US$156,773	5,526 -1.9%	28.37	US$156,773
2026-05-06	2026-05-04	PlS Planned sale	Lillie James Woodruff Chief Scientific Officer Officer	9,250 -3.1% 27.50 US$254,375	9,250 -3.1%	27.50	US$254,375
2026-05-06	2026-05-04	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	700 -0.2% 30.08 US$21,056	700 -0.2%	30.08	US$21,056
2026-05-06	2026-05-04	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	312 -0.1% 29.56 US$9,223	312 -0.1%	29.56	US$9,223
2026-05-06	2026-05-04	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	5,460 -1.4% 28.37 US$154,900	5,460 -1.4%	28.37	US$154,900
2026-05-06	2026-05-04	PlS Planned sale	Foff Erin Pennock Chief Medical Officer Officer	9,180 -2.3% 27.50 US$252,450	9,180 -2.3%	27.50	US$252,450
2026-05-04	2026-05-04	PrS Proposed sale	Kroeger Christopher A. Officer Officer	236,470 30.70 US$7,259,629	236,470	30.70	US$7,259,629
2026-05-04	2026-05-04	PrS Proposed sale	Setia Vishwas Officer Officer	36,371 30.70 US$1,116,590	36,371	30.70	US$1,116,590
2026-05-04	2026-05-04	PrS Proposed sale	Foff Erin Pennock Officer Officer	54,718 30.70 US$1,679,843	54,718	30.70	US$1,679,843
2026-05-04	2026-05-04	PrS Proposed sale	Lillie James Woodruff Officer Officer	52,428 30.70 US$1,609,540	52,428	30.70	US$1,609,540
2026-05-04	2026-05-04	PrS Proposed sale	Hanson Kristopher Officer Officer	27,834 30.70 US$854,504	27,834	30.70	US$854,504
2026-04-29	2026-04-28	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	700 -0.4% 30.83 US$21,581	700 -0.4%	30.83	US$21,581
2026-04-29	2026-04-28	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	17,235 -8.7% 30.33 US$522,738	17,235 -8.7%	30.33	US$522,738
2026-04-29	2026-04-28	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	17,235 -8.7% 30.33 US$522,738	17,235 -8.7%	30.33	US$522,738
2026-04-29	2026-04-27	PlS Planned sale	Kreitzer Anatol Chief Discovery Officer Officer	7,821 -3.6% 30.50 US$238,540	7,821 -3.6%	30.50	US$238,540
2026-04-29	2026-04-27	PlS Planned sale	Kreitzer Anatol Chief Discovery Officer Officer	29,255 -11.8% 29.63 US$866,826	29,255 -11.8%	29.63	US$866,826
2026-04-29	2026-04-27	PlS Planned sale	Kreitzer Anatol Chief Discovery Officer Officer	8,346 -3.3% 28.96 US$241,700	8,346 -3.3%	28.96	US$241,700
2026-04-29	2026-04-27	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	14,363 -6.7% 30.46 US$437,497	14,363 -6.7%	30.46	US$437,497
2026-04-29	2026-04-27	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	14,363 -6.7% 30.46 US$437,497	14,363 -6.7%	30.46	US$437,497
2026-04-29	2026-04-27	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	29,623 -12.2% 29.60 US$876,841	29,623 -12.2%	29.60	US$876,841
2026-04-29	2026-04-27	PlS Planned sale	GILLIS JONATHAN CAAO and PAO Officer	7,914 -3.2% 28.94 US$229,031	7,914 -3.2%	28.94	US$229,031
2026-04-27	2026-04-27	PrS Proposed sale	JONATHAN GILLIS Officer Officer	69,835 29.76 US$2,078,290	69,835	29.76	US$2,078,290
2026-04-27	2026-04-27	PrS Proposed sale	ANATOL KREITZER Officer Officer	45,422 29.76 US$1,351,759	45,422	29.76	US$1,351,759
2026-04-17	2026-04-16	S Sale	Setia Vishwas Chief Financial Officer Officer	87 -0.0% 27.49 US$2,392	87 -0.0%	27.49	US$2,392
2026-04-17	2026-04-16	S Sale	Setia Vishwas Chief Financial Officer Officer	29 -0.0% 27.01 US$783	29 -0.0%	27.01	US$783
2026-04-17	2026-04-16	S Sale	Kroeger Christopher A. Chief Executive Officer Executive Director	7,575 -0.5% 27.49 US$208,237	7,575 -0.5%	27.49	US$208,237
2026-04-17	2026-04-16	S Sale	Kroeger Christopher A. Chief Executive Officer Executive Director	2,477 -0.2% 27.01 US$66,904	2,477 -0.2%	27.01	US$66,904